ClinicalTrials.Veeva

Menu

A Novel Nomogram to Predict Severity of COVID-19

A

Army Medical University of People's Liberation Army

Status

Completed

Conditions

Nomogram Model
COVID-19 Disease

Treatments

Other: other

Study type

Observational

Funder types

Other

Identifiers

NCT04366024
XQonc-016

Details and patient eligibility

About

Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict covid-19 disease severity, which could provide important assistance and supplement for clinical work. In the case of extremely shortage of front-line medical resources, patients with potential severe diseases will be timely treated with the help of the novel nomogram model.

Enrollment

1,000 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID-19 disease patients confirmed by virus nucleic acid RT-PCR and CT

Exclusion criteria

  • unconfirmed suspected cases
  • Patients during pregnancy and lactation
  • incomplete clinical data
  • investigators considered patients ineligible for the trial
  • Child patients

Trial design

1,000 participants in 1 patient group

Observed group
Description:
COVID-19 disease patients who were detected by RT-PCR and CT imaging.
Treatment:
Other: other

Trial contacts and locations

1

Loading...

Central trial contact

Jianguo Sun

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems